(Q47580544)

4 February 2018

title

Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury (English)

1 reference

4 February 2018

1 reference

7

1 reference

4 February 2018

Gerard Pasterkamp

9

object named as

Gerard Pasterkamp

1 reference

4 February 2018

Vince C De Hoog

1

1 reference

4 February 2018

Leo Timmers

2

1 reference

4 February 2018

Amerik Van Duijvenvoorde

3

1 reference

4 February 2018

Saskia C A De Jager

4

1 reference

4 February 2018

Ben J Van Middelaar

5

1 reference

4 February 2018

Mirjam B Smeets

6

1 reference

4 February 2018

Pieter A Doevendans

8

1 reference

4 February 2018

C Erik Hack

10

1 reference

4 February 2018

Dominique P V De Kleijn

11

1 reference

4 February 2018

publication date

15 June 2014

1 reference

4 February 2018

published in

Cardiovascular Research

1 reference

4 February 2018

volume

103

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

521-529

1 reference

4 February 2018

Progression in attenuating myocardial reperfusion injury: an overview

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

How can we cure a heart "in flame"? A translational view on inflammation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Role of complement and perspectives for intervention in ischemia-reperfusion damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Complement mediators in ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery Occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

The innate immune response in reperfused myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

C-reactive protein activates complement in infarcted human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

IgM colocalises with complement and C reactive protein in infarcted human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Inhibiting the C5-C5a receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Function, structure and therapeutic potential of complement C5a receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Structure, function and cellular expression of complement anaphylatoxin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Ischemia-reperfusion and immediate T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Regulation of the inflammatory response in cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

The immune system and cardiac repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

The role of neutrophils in myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Neutrophils--a key component of ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Regulatory T cells ameliorate cardiac remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Complement regulation of T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Role and mechanism of action of complement in regulating T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU153

21 January 2018

Identifiers

DOI

10.1093/CVR/CVU153

1 reference

4 February 2018

PubMed ID

24935433

1 reference

4 February 2018